In this study, we uncovered for the first time that high USP21 promotes colorectal cancer (CRC) cell proliferation and progression, correlates with adverse patient prognosis, induces immunosuppression in TME, and confers resistance to immunotherapy. This evidence concerns the gene USP21 and colorectal carcinoma.